The additive miotic effects of dapiprazole and pilocarpine. 1995

O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
Department of Ophthalmology, Sourasky Medical Center, Tel-Aviv, Israel.

BACKGROUND Since dapiprazole on alpha-adrenergic agent, produces miosis by paralyzing the dilator muscle, and pilocarpine, a parasympathetic drug, causes miosis by affecting the sphincter, we speculated that the two drugs might have additive effects. METHODS The additive miotic actions of pilocarpine 2% and dapiprazole 0.5% were evaluated by comparing the effects of two drugs given together and alone on the reversal of mydriasis induced by tropicamide (0.5%) and phenylephrine (10%) in one eye each of 60 healthy volunteers. RESULTS Dapiprazole and pilocarpine together induced miosis significantly faster than each drug alone, showing additive effects. CONCLUSIONS Co-administration of dapiprazole and pilocarpine at the end of the eye examination will induce fast pupillary constriction, which might be useful in preventing the development of an acute attack of angle-closure glaucoma in patients with anatomically narrow angles.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D010277 Parasympathomimetics Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. Parasympathomimetic Agents,Parasympathomimetic Drugs,Parasympathomimetic Effect,Parasympathomimetic Effects,Agents, Parasympathomimetic,Drugs, Parasympathomimetic,Effect, Parasympathomimetic,Effects, Parasympathomimetic
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D010862 Pilocarpine A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. Isopilocarpine,Isoptocarpine,Ocusert,Pilocarpine Hydrochloride,Pilocarpine Mononitrate, (3S-cis)-Isomer,Pilocarpine Nitrate,Pilocarpine, Monohydrochloride, (3S-cis)-Isomer,Salagen,Hydrochloride, Pilocarpine,Nitrate, Pilocarpine
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011680 Pupil The aperture in the iris through which light passes. Pupils
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
December 1995, Journal of glaucoma,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
January 1976, Vestnik oftalmologii,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
November 1997, The Journal of pharmacy and pharmacology,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
January 2009, Journal of cataract and refractive surgery,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
January 1982, Vestnik oftalmologii,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
September 1978, Journal of pharmaceutical sciences,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
October 1969, Nihon ganka kiyo,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
January 1978, Vestnik oftalmologii,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
July 1999, International journal of pharmaceutics,
O Geyer, and A Loewenstein, and B Shalmon, and M Neudorfer, and M Lazar
March 1998, Neurology,
Copied contents to your clipboard!